Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05138601 · ClinicalTrials.gov registry record · NA

Remote Monitoring and Virtual Collaborative Care For Hypertension Control to Prevent Cognitive Decline Phase II

A NA study of Hypertension, sponsored by University of Kansas Medical Center.

Active
Registry status
NA
Development phase
1,000
Enrollment target
2
Study locations

NCT05138601 is a NA study of Hypertension that is active but no longer recruiting, run by University of Kansas Medical Center. The registered enrollment target is 1,000 participants, below the 3,505-participant average among 470 other Hypertension trials with a reported enrollment target (71% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05138601, a NA study of Hypertension, is active but no longer recruiting, sponsored by University of Kansas Medical Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
1,000 participants
Enrollment target
2
Study locations

Study Summary

This is a randomized, controlled, pragmatic trial designed as a "type I hybrid effectiveness-implementation trial" that tests a hypertension program integrating a virtual Collaborative Care Clinic (vCCC), home blood pressure monitoring, and telehealth for lowering blood pressure (BP) in two health systems.

Conditions Studied

Interventions

  • OTHER Virtual Collaborative Care Clinic

Study Locations (2)

Kansas

  • University of Kansas Health System - Kansas City

Utah

  • University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2021-11-16
Est. Completion 2026-12-31
Phase NA

Sponsor

University of Kansas Medical Center

408 total trials

What the Registry Record Tells You About NCT05138601

The ClinicalTrials.gov registry entry for NCT05138601 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,505-participant average among 470 other Hypertension trials with a reported enrollment target (71% lower). The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Virtual Collaborative Care Clinic is the first listed.

NCT05138601 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Kansas, Utah.

Frequently Asked Questions

What is clinical trial NCT05138601 about?

NCT05138601 is a clinical study titled "Remote Monitoring and Virtual Collaborative Care For Hypertension Control to Prevent Cognitive Decline Phase II". This is a randomized, controlled, pragmatic trial designed as a "type I hybrid effectiveness-implementation trial" that tests a hypertension program integrating a virtual Collaborative Care Clinic (vCCC), home blood pressure monitoring, and telehealth for lowering blood pressure (BP) in two health s...

What is the current status of trial NCT05138601?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2021-11-16. Estimated completion is 2026-12-31.

What conditions does trial NCT05138601 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT05138601?

The interventions under investigation include: Virtual Collaborative Care Clinic (OTHER).

Who is sponsoring clinical trial NCT05138601?

This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05138601 being conducted?

This trial has 2 study locations across Kansas, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.